Abercrombie & Fitch (ANF) 10-Q/A 6 Jun 17 2017 Q1 Quarterly report (amended) Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Apr. 29, 2017	Jun. 01, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	ABERCROMBIE & FITCH CO /DE/
Entity Central Index Key	1,018,840
Current Fiscal Year End Date	--02-03
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Apr. 29, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Common Stock, Shares Outstanding		68,016,186

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Net sales	$ 661,099	$ 685,483
Cost of sales, exclusive of depreciation and amortization	262,174	259,762
Gross profit	398,925	425,721
Stores and distribution expense	359,929	369,118
Marketing, general and administrative expense	109,893	114,447
Asset impairment	730	0
Other operating income, net	(1,686)	(2,933)
Operating loss	(69,941)	(54,911)
Interest expense, net	4,120	4,506
Loss before taxes	(74,061)	(59,417)
Income tax benefit	(13,052)	(20,787)
Net loss	(61,009)	(38,630)
Less: Net income attributable to noncontrolling interests	691	957
Net loss attributable to Abercrombie & Fitch Co.	$ (61,700)	$ (39,587)
Net loss per share attributable to Abercrombie & Fitch Co.
Basic	$ (0.91)	$ (0.59)
Diluted	$ (0.91)	$ (0.59)
Weighted-average shares outstanding
Basic	68,073	67,625
Diluted	68,073	67,625
Dividends declared per share	$ 0.2	$ 0.2
Other comprehensive income
Foreign currency translation, net of tax	$ 5,607	$ 20,425
Derivative financial instruments, net of tax	(4,600)	(9,955)
Other comprehensive income	1,007	10,470
Comprehensive loss	(60,002)	(28,160)
Less: Comprehensive income attributable to noncontrolling interests	691	957
Comprehensive loss attributable to Abercrombie & Fitch Co.	$ (60,693)	$ (29,117)

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Apr. 29, 2017	Jan. 28, 2017
Current assets:
Cash and equivalents	$ 421,441	$ 547,189
Receivables	90,346	93,384
Inventories, net	398,750	399,795
Other current assets	91,565	98,932
Total current assets	1,002,102	1,139,300
Property and equipment, net	806,057	824,738
Other assets	349,806	331,719
Total assets	2,157,965	2,295,757
Current liabilities:
Accounts payable	147,531	187,017
Accrued expenses	248,915	273,044
Short-term portion of deferred lease credits	19,522	20,076
Income taxes payable	5,264	5,863
Total current liabilities	421,232	486,000
Long-term liabilities:
Long-term portion of deferred lease credits	75,886	76,321
Long-term portion of borrowings, net	263,353	262,992
Leasehold financing obligations	47,120	46,397
Other liabilities	169,588	172,008
Total long-term liabilities	555,947	557,718
Stockholders’ equity
Class A Common Stock - $0.01 par value: 150,000 shares authorized and 103,300 shares issued at each of April 29, 2017 and January 28, 2017	1,033	1,033
Paid-in capital	387,394	396,590
Retained earnings	2,393,693	2,474,703
Accumulated other comprehensive loss, net of tax	(120,295)	(121,302)
Treasury stock, at average cost: 35,288 and 35,542 shares at April 29, 2017 and January 28, 2017, respectively	(1,489,853)	(1,507,589)
Total Abercrombie & Fitch Co. stockholders’ equity	1,171,972	1,243,435
Noncontrolling interests	8,814	8,604
Total stockholders’ equity	1,180,786	1,252,039
Total liabilities and stockholders’ equity	$ 2,157,965	$ 2,295,757

Condensed Consolidated Balance4

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Apr. 29, 2017	Jan. 28, 2017
Stockholders’ equity
Treasury Stock, at Average Cost (in shares)	35,288,000	35,542,000
Class A Common Stock
Stockholders’ equity
Class A Common Stock, par value	$ 0.01	$ 0.01
Class A Common Stock, shares authorized	150,000,000	150,000,000
Class A Common Stock, shares issued	103,300,000	103,300,000

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Operating activities
Net loss	$ (61,009)	$ (38,630)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization	48,789	50,866
Asset impairment	730	0
Loss on disposal	2,378	1,287
Amortization of deferred lease credits	(5,325)	(6,506)
Benefit from deferred income taxes	(15,100)	(21,195)
Share-based compensation	4,880	6,599
Net tax deficit on share-based compensation	9,264	951
Changes in assets and liabilities
Inventories, net	1,316	3,547
Accounts payable and accrued expenses	(62,120)	(63,748)
Lessor construction allowances	2,940	1,881
Income taxes	8,630	(3,888)
Long-term lease deposits	(41)	23,309
Other assets	8,367	(10,283)
Other liabilities	(9,433)	(17,996)
Net cash used by operating activities	(84,262)	(75,708)
Investing activities
Purchases of property and equipment	(32,081)	(25,983)
Proceeds from sale of property and equipment	203	4,098
Net cash used for investing activities	(31,878)	(21,885)
Financing activities
Dividends paid	(13,554)	(13,471)
Other financing activities	(551)	(372)
Net cash used for financing activities	(14,105)	(13,843)
Effect of exchange rates on cash	4,497	13,833
Net decrease in cash and equivalents	(125,748)	(97,603)
Cash and equivalents, beginning of period	547,189	588,578
Cash and equivalents, end of period	421,441	490,975
Significant non-cash investing activities
Change in accrual for construction in progress	(4,297)	(21)
Supplemental information
Cash paid for interest	3,391	3,763
Cash paid for income taxes, net of refunds	$ 3,364	$ 15,969

Basis of Presentation

Basis of Presentation	3 Months Ended
	Apr. 29, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION Nature of Business Abercrombie & Fitch Co. (“A&F”), through its subsidiaries (collectively, A&F and its subsidiaries are referred to as “Abercrombie & Fitch” or the “Company”), is a specialty retailer of branded apparel and accessories. The Company operates through store and direct-to-consumer operations, as well as through various wholesale, franchise and licensing arrangements. The Company has operations in North America, Europe, Asia and the Middle East. Principles of Consolidation The accompanying Condensed Consolidated Financial Statements include historical financial statements of, and transactions applicable to, the Company and reflect its assets, liabilities, results of operations and cash flows. The Company has interests in a United Arab Emirates business venture and in a Kuwait business venture with Majid al Futtaim Fashion L.L.C. (“MAF”), each of which meets the definition of a variable interest entity (“VIE”). The Company is deemed to be the primary beneficiary of these VIEs; therefore, the Company has consolidated the assets, liabilities, results of operations and cash flows of these VIEs. Fiscal Year The Company’s fiscal year ends on the Saturday closest to January 31. All references herein to “Fiscal 2017 ” and “Fiscal 2016 ” represent the fifty-three week fiscal year ending on February 3, 2018 and the fifty-two week fiscal year ended on January 28, 2017 , respectively. Interim Financial Statements The Condensed Consolidated Financial Statements as of April 29, 2017 , and for the thirteen week periods ended April 29, 2017 and April 30, 2016 , are unaudited and are presented pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, these Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto contained in A&F’s Annual Report on Form 10-K for Fiscal 2016 filed with the SEC on March 27, 2017 . The January 28, 2017 consolidated balance sheet data, included herein, were derived from audited consolidated financial statements, but do not include all disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”). In the opinion of management, the accompanying Condensed Consolidated Financial Statements reflect all adjustments (which are of a normal recurring nature) necessary to state fairly, in all material respects, the financial position and results of operations and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for Fiscal 2017 . Recent Accounting Pronouncements The following table provides a brief description of recent accounting pronouncements that could affect the Company’s financial statements: Accounting Standards Update (ASU) Description Date of Adoption Effect on the Financial Statements or Other Significant Matters Standards adopted ASU 2015-11, Simplifying the Measurement of Inventory This update amends ASC 330, Inventory . The new guidance applies to inventory measured using first-in, first-out (FIFO) or average cost. Under this amendment, inventory is to be measured at the lower of cost and net realizable value, which is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. January 29, 2017* The adoption of this guidance did not have any impact on the Company's consolidated financial statements. ASU 2016-09, Compensation—Stock Compensation This update amends ASC 718, Compensation . Under the new guidance, tax benefits and certain tax deficiencies arising from the vesting of share-based payments are to be recognized as income tax benefits or expenses in the statement of operations; whereas, under the previous guidance, such benefits and deficiencies were recorded in additional paid-in-capital. The cash flow effects of the tax benefit are to be reported in cash flows from operating activities; whereas, they were previously reported in cash flows from financing activities. This guidance also allows for entities to make a policy election to estimate forfeitures or account for them when they occur. January 29, 2017* As required by the update, all excess tax benefits and tax deficiencies recognized on share-based compensation expense are reflected in the condensed consolidated statements of income as a component of the provision for income taxes on a prospective basis. This update resulted in additional non-cash income tax expense of $9.3 million in the first quarter of Fiscal 2017. In addition, excess tax benefits and tax deficiencies recognized on share-based compensation expense are now classified as an operating activity on the condensed consolidated statements of cash flows. The Company has applied this provision on a retrospective basis. For the first quarter of Fiscal 2016, net cash used by operating activities decreased by $0.6 million with a corresponding offset to net cash used for financing activities. The Company has elected to maintain its practice of estimating forfeitures when recognizing expense for share-based payment awards rather than accounting for forfeitures when they occur. Based on share-based compensation awards currently outstanding at current stock prices, the adoption of this guidance will result in non-cash income tax expense of approximately $11 million for Fiscal 2017 and $20 million for Fiscal 2018. Standards not yet adopted ASU 2014-09, Revenue from Contracts with Customers This update supersedes the revenue recognition requirements in ASC 605, Revenue Recognition . The new guidance requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration which the entity expects to be entitled to in exchange for those goods or services. February 4, 2018 The Company is currently evaluating the impact that this guidance will have on its consolidated financial statements. ASU 2016-02, Leases This update supersedes the leasing requirements in ASC 840, Leases . The new guidance requires an entity to recognize lease assets and lease liabilities on the balance sheet and disclose key leasing information that depicts the lease rights and obligations of an entity. February 3, 2019* The Company expects that this guidance will result in a significant increase in the Company’s long-term assets and long-term liabilities on the Company's consolidated balance sheets, and is currently evaluating additional impacts that it may have on its consolidated financial statements. * Early adoption is permitted.

Net Loss Per Share

Net Loss Per Share	3 Months Ended
	Apr. 29, 2017
Earnings Per Share [Abstract]
NET LOSS PER SHARE	NET LOSS PER SHARE Net loss per basic and diluted share is computed based on the weighted-average number of outstanding shares of common stock. The following table presents weighted-average shares outstanding and anti-dilutive shares: Thirteen Weeks Ended (in thousands) April 29, 2017 April 30, 2016 Shares of common stock issued 103,300 103,300 Weighted-average treasury shares (35,227 ) (35,675 ) Weighted-average — basic shares 68,073 67,625 Dilutive effect of share-based compensation awards — — Weighted-average — diluted shares 68,073 67,625 Anti-dilutive shares (1) 5,263 7,954 (1) Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net loss per diluted share because the impact would have been anti-dilutive.

Fair Value

Fair Value	3 Months Ended
	Apr. 29, 2017
Fair Value Disclosures [Abstract]
FAIR VALUE	FAIR VALUE Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The inputs used to measure fair value are prioritized based on a three-level hierarchy. The three levels of inputs to measure fair value are as follows: • Level 1—inputs are unadjusted quoted prices for identical assets or liabilities that are available in active markets that the Company can access at the measurement date. • Level 2—inputs are other than quoted market prices included within Level 1 that are observable for assets or liabilities, directly or indirectly. • Level 3—inputs to the valuation methodology are unobservable. The lowest level of significant input determines the placement of the entire fair value measurement in the hierarchy. The three levels of the hierarchy and the distribution within it of the Company’s assets and liabilities, which are measured at fair value on a recurring basis, were as follows: Assets and Liabilities at Fair Value as of April 29, 2017 (in thousands) Level 1 Level 2 Level 3 Total Assets: Trust-owned life insurance policies (at cash surrender value) $ — $ 100,417 $ — $ 100,417 Money market funds 21 — — 21 Derivative financial instruments — 2,415 — 2,415 Total assets $ 21 $ 102,832 $ — $ 102,853 Liabilities: Derivative financial instruments $ — $ 1,243 $ — $ 1,243 Total liabilities $ — $ 1,243 $ — $ 1,243 Assets at Fair Value as of January 28, 2017 (in thousands) Level 1 Level 2 Level 3 Total Assets: Trust-owned life insurance policies (at cash surrender value) $ — $ 99,654 $ — $ 99,654 Money market funds 94,026 — — 94,026 Derivative financial instruments — 6,042 — 6,042 Total assets $ 94,026 $ 105,696 $ — $ 199,722 Liabilities: Derivative financial instruments $ — $ 492 $ — $ 492 Total liabilities $ — $ 492 $ — $ 492 The Level 2 assets and liabilities consist of trust-owned life insurance policies and derivative financial instruments, primarily foreign currency exchange forward contracts. The fair value of foreign currency exchange forward contracts is determined by using quoted market prices of the same or similar instruments, adjusted for counterparty risk. Fair value of borrowings: The Company’s borrowings under the Company’s credit facilities are carried at historical cost in the accompanying Condensed Consolidated Balance Sheets. For disclosure purposes, the Company estimated the fair value of borrowings outstanding based on market rates for similar types of debt, which are considered to be Level 2 inputs. The carrying amount and fair value of the Company’s term loan facility were as follows: (in thousands) April 29, 2017 January 28, 2017 Gross borrowings outstanding, carrying amount $ 268,250 $ 268,250 Gross borrowings outstanding, fair value $ 258,861 $ 260,551 No borrowings were outstanding under the Company’s senior secured revolving credit facility as of April 29, 2017 or January 28, 2017 .

Property and Equipment, Net

Property and Equipment, Net	3 Months Ended
	Apr. 29, 2017
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT, NET	PROPERTY AND EQUIPMENT, NET Property and equipment, net consisted of: (in thousands) April 29, 2017 January 28, 2017 Property and equipment, at cost $ 2,766,557 $ 2,772,139 Less: Accumulated depreciation and amortization (1,960,500 ) (1,947,401 ) Property and equipment, net $ 806,057 $ 824,738 Long-lived assets, primarily comprised of leasehold improvements, furniture, fixtures and equipment, are tested for recoverability whenever events or changes in circumstances indicate that the carrying amount of the long-lived assets might not be recoverable. These include, but are not limited to, material declines in operational performance, a history of losses, an expectation of future losses, adverse market conditions and store closure or relocation decisions. On at least a quarterly basis, the Company reviews for indicators of impairment at the individual store level, the lowest level for which cash flows are identifiable. Stores that display an indicator of impairment are subjected to an impairment assessment. The Company’s impairment assessment requires management to make assumptions and judgments related, but not limited, to management’s expectations for future operations and projected cash flows. The key assumptions used in the Company’s undiscounted future cash flow models include sales, gross profit and, to a lesser extent, operating expenses. An impairment loss would be recognized when these undiscounted future cash flows are less than the carrying amount of the asset group. In the circumstance of impairment, the loss would be measured as the excess of the carrying amount of the asset group over its fair value. The key assumptions used in estimating the fair value of impaired assets include projected cash flows and discount rate. The Company incurred asset impairment charges of $0.7 million for the thirteen weeks ended April 29, 2017 . There were no asset impairment charges for the thirteen weeks ended April 30, 2016 . The Company had $35.9 million and $35.6 million of construction project assets in property and equipment, net at April 29, 2017 and January 28, 2017 , respectively, related to the construction of buildings in certain lease arrangements where the Company is deemed to be the owner of the construction project.

Income Taxes

Income Taxes	3 Months Ended
	Apr. 29, 2017
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The Company’s quarterly tax provision and the estimate of the annual effective tax rate are subject to significant variation due to several factors. These include variability in the pre-tax jurisdictional mix of earnings, changes in how the Company does business including entering into new businesses or geographies, changes in foreign currency exchange rates, changes in law, regulations, and administrative practices, relative changes of expenses or losses for which tax benefits are not recognized and the impact of discrete items. The impact of these items on the effective tax rate will be greater at lower levels of pre-tax income (loss). In the first quarter of Fiscal 2017, the provision for income taxes also differs from the tax computed at the U.S. federal statutory tax rate due to the tax effects of stock-based compensation. In the first quarter of Fiscal 2017, the Company adopted ASU 2016-09, “Compensation—Stock Compensation,” which resulted in a discrete non-cash income tax charge of $9.3 million recognized in income tax benefit on the Condensed Consolidated Statements of Operations and Comprehensive Loss. Refer to Note 1, “ BASIS OF PRESENTATION--Recent Accounting Pronouncements ” for further discussion regarding the adoption of this standard.

Share-Based Compensation

Share-Based Compensation	3 Months Ended
	Apr. 29, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
SHARE-BASED COMPENSATION	SHARE-BASED COMPENSATION The Company recognized share-based compensation expense of $4.9 million for the thirteen weeks ended April 29, 2017 and $6.6 million for the thirteen weeks ended April 30, 2016 . The tax benefit associated with share-based compensation expense was $1.9 million for the thirteen weeks ended April 29, 2017 and $2.5 million for the thirteen weeks ended April 30, 2016 . Stock Options The following table summarizes stock option activity for the thirteen weeks ended April 29, 2017 : Number of Underlying Shares Weighted-Average Exercise Price Aggregate Intrinsic Value Weighted-Average Remaining Contractual Life Outstanding at January 28, 2017 189,800 $ 76.62 Granted — — Exercised — — Forfeited or expired (75,000 ) 73.42 Outstanding at April 29, 2017 114,800 $ 78.71 $ — 0.8 Stock options exercisable at April 29, 2017 114,800 $ 78.71 $ — 0.8 Stock Appreciation Rights The following table summarizes stock appreciation rights activity for the thirteen weeks ended April 29, 2017 : Number of Underlying Shares Weighted-Average Exercise Price Aggregate Intrinsic Value Weighted-Average Remaining Contractual Life Outstanding at January 28, 2017 4,079,050 $ 47.49 Granted — — Exercised — — Forfeited or expired (888,197 ) 44.34 Outstanding at April 29, 2017 3,190,853 $ 48.50 $ — 3.0 Stock appreciation rights exercisable at April 29, 2017 2,841,662 $ 51.22 $ — 2.5 Stock appreciation rights expected to become exercisable in the future as of April 29, 2017 267,161 $ 26.63 $ — 7.7 As of April 29, 2017 , there was $2.1 million of total unrecognized compensation cost, net of estimated forfeitures, related to stock appreciation rights. The unrecognized compensation cost is expected to be recognized over a weighted-average period of 11 months . The grant date fair value of stock appreciation rights that vested during the thirteen weeks ended April 29, 2017 and April 30, 2016 was $1.9 million and $3.7 million , respectively. Restricted Stock Units The following table summarizes activity for restricted stock units for the thirteen weeks ended April 29, 2017 : Service-based Restricted Stock Units Performance-based Restricted Stock Units Market-based Restricted Stock Units Number of Underlying Shares (1) Weighted- Average Grant Date Fair Value Number of Underlying Shares Weighted- Average Grant Date Fair Value Number of Underlying Shares Weighted- Average Grant Date Fair Value Unvested at January 28, 2017 1,915,461 $ 25.47 203,923 $ 22.53 184,892 $ 26.89 Granted 1,408,972 9.61 524,030 9.11 236,872 11.79 Adjustments for performance achievement — — — — — — Vested (466,291 ) 28.86 — — — — Forfeited (122,813 ) 22.37 (5,163 ) 25.15 (5,165 ) 29.55 Unvested at April 29, 2017 2,735,329 $ 16.81 722,790 $ 12.26 416,599 $ 17.25 (1) This includes 786,449 unvested restricted stock units as of April 29, 2017 that are subject to the requirement that the Company must achieve at least $1.00 of GAAP net income attributable to A&F for the fiscal year in order to vest. Fair value of both service-based and performance-based restricted stock units is calculated using the market price of the underlying common stock on the date of grant reduced for anticipated dividend payments on unvested shares. In determining fair value, the Company does not take into account performance-based vesting requirements. Performance-based vesting requirements are taken into account in determining the number of awards expected to vest. For market-based restricted stock units, fair value is calculated using a Monte Carlo simulation with the number of shares that ultimately vest dependent on the Company’s total stockholder return measured against the total stockholder return of a select group of peer companies over a three-year period. For an award with performance-based or market-based vesting requirements, the number of shares that ultimately vest can vary from 0% to 200% of target depending on the level of achievement of performance criteria. Unvested shares related to restricted stock units with performance-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Service-based restricted stock units are expensed on a straight-line basis over the total requisite service period, net of forfeitures. Performance-based restricted stock units subject to graded vesting are expensed on an accelerated attribution basis, net of forfeitures. Market-based restricted stock units without graded vesting features are expensed on a straight-line basis over the requisite service period, net of forfeitures. As of April 29, 2017 , there was $30.1 million , $4.9 million and $4.8 million of total unrecognized compensation cost, net of estimated forfeitures, related to service-based, performance-based and market-based restricted stock units, respectively. The unrecognized compensation cost is expected to be recognized over a weighted-average period of 17 months , 18 months and 16 months for service-based, performance-based and market-based restricted stock units, respectively. The tax benefit associated with restricted stock vesting during the thirteen weeks ended April 29, 2017 and April 30, 2016 was $2.1 million and $4.9 million , respectively. Additional information pertaining to restricted stock units for the thirteen weeks ended April 29, 2017 and April 30, 2016 follows: (in thousands) April 29, 2017 April 30, 2016 Service-based restricted stock units: Total grant date fair value of awards granted $ 13,540 $ 21,445 Total grant date fair value of awards vested 13,457 12,892 Performance-based restricted stock units: Total grant date fair value of awards granted $ 4,774 $ 2,762 Total grant date fair value of awards vested — 1,151 Market-based restricted stock units: Total grant date fair value of awards granted $ 2,793 $ 3,601 Total grant date fair value of awards vested — — The weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the thirteen weeks ended April 29, 2017 and April 30, 2016 were as follows: April 29, 2017 April 30, 2016 Grant date market price $ 11.43 $ 31.67 Fair value $ 11.79 $ 38.22 Assumptions: Price volatility 47 % 44 % Expected term (years) 2.9 2.8 Risk-free interest rate 1.5 % 1.1 % Dividend yield 7.0 % 2.5 % Average volatility of peer companies 35.2 % 34.4 % Average correlation coefficient of peer companies 0.2664 0.3382

Derivative Instruments

Derivative Instruments	3 Months Ended
	Apr. 29, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS	DERIVATIVE INSTRUMENTS The Company is exposed to risks associated with changes in foreign currency exchange rates and uses derivative instruments, primarily forward contracts, to manage the financial impacts of these exposures. The Company does not use forward contracts to engage in currency speculation and does not enter into derivative financial instruments for trading purposes. The Company uses derivative instruments, primarily forward contracts designated as cash flow hedges, to hedge the foreign currency exposure associated with forecasted foreign-currency-denominated intercompany inventory sales to foreign subsidiaries and the related settlement of the foreign-currency-denominated intercompany receivables. Fluctuations in exchange rates will either increase or decrease the Company’s intercompany equivalent cash flows and affect the Company’s U.S. Dollar earnings. Gains or losses on the foreign currency exchange forward contracts that are used to hedge these exposures are expected to partially offset this variability. Foreign currency exchange forward contracts represent agreements to exchange the currency of one country for the currency of another country at an agreed upon settlement date. These forward contracts typically have a maximum term of twelve months . The sale of the inventory to the Company’s customers will result in the reclassification of related derivative gains and losses that are reported in accumulated other comprehensive loss (“AOCL”). Substantially all of the unrealized gains or losses related to designated cash flow hedges as of April 29, 2017 will be recognized in cost of sales, exclusive of depreciation and amortization, over the next twelve months . The Company presents its derivative assets and derivative liabilities at their gross fair values on the Condensed Consolidated Balance Sheets. However, the Company's Master International Swap Dealers Association, Inc., Agreement and other similar arrangements allow net settlements under certain conditions. As of April 29, 2017 , the Company had outstanding the following foreign currency exchange forward contracts that were entered into to hedge either a portion, or all, of forecasted foreign-currency-denominated intercompany inventory sales, the resulting settlement of the foreign-currency-denominated intercompany accounts receivable, or both: (in thousands) Notional Amount (1) Euro $ 81,038 British pound $ 30,243 Canadian dollar $ 15,119 Japanese yen $ 7,934 (1) Amounts reported are the U.S. Dollar notional amounts outstanding as of April 29, 2017 . The Company also uses foreign currency exchange forward contracts to hedge certain foreign-currency-denominated net monetary assets/liabilities. Examples of monetary assets/liabilities include cash balances, receivables and payables. Fluctuations in exchange rates result in transaction gains/(losses) being recorded in earnings as U.S. GAAP requires that monetary assets/liabilities be remeasured at the spot exchange rate at quarter-end or upon settlement. The Company has chosen not to apply hedge accounting to these instruments because there are no differences in the timing of gain or loss recognition on the hedging instruments and the hedged items. As of April 29, 2017 , the Company had outstanding the following foreign currency exchange forward contracts that were entered into to hedge foreign-currency-denominated net monetary assets/liabilities: (in thousands) Notional Amount (1) Euro $ 13,895 British pound $ 1,283 (1) Amounts reported are the U.S. Dollar notional amounts outstanding as of April 29, 2017 . The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets as of April 29, 2017 and January 28, 2017 were as follows: (in thousands) Location April 29, January 28, Location April 29, January 28, Derivatives designated as hedging instruments: Foreign currency exchange forward contracts Other current assets $ 2,415 $ 5,920 Accrued expenses $ 1,226 $ 486 Derivatives not designated as hedging instruments: Foreign currency exchange forward contracts Other current assets $ — $ 122 Accrued expenses $ 17 $ 6 Total Other current assets $ 2,415 $ 6,042 Accrued expenses $ 1,243 $ 492 Refer to Note 3, “ FAIR VALUE, ” for further discussion of the determination of the fair value of derivative instruments. The location and amounts of derivative gains and losses for the thirteen weeks ended April 29, 2017 and April 30, 2016 on the Condensed Consolidated Statements of Operations and Comprehensive Loss were as follows: Thirteen Weeks Ended April 29, 2017 April 30, 2016 (in thousands) Location Gain/(Loss) Gain/(Loss) Derivatives not designated as hedging instruments: Foreign currency exchange forward contracts Other operating income, net $ 28 $ (1,777 ) Effective Portion Ineffective Portion and Amount Excluded from Effectiveness Testing Amount of Loss Recognized in OCI on Derivative Contracts (1) Location of Gain Reclassified from AOCL into Earnings Amount of Gain Reclassified from AOCL into Earnings (2) Location of Gain Recognized in Earnings on Derivative Contracts Amount of Gain Recognized in Earnings on Derivative Contracts (3) Thirteen Weeks Ended (in thousands) April 29, April 30, April 29, April 30, April 29, April 30, Derivatives in cash flow hedging relationships: Foreign currency exchange forward contracts $ (1,373 ) $ (9,382 ) Cost of sales, exclusive of depreciation and amortization $ 3,535 $ 2,305 Other operating income, net $ 528 $ 355 (1) The amount represents the change in fair value of derivative contracts due to changes in spot rates. (2) The amount represents the reclassification from AOCL into earnings when the hedged item affects earnings, which is when merchandise is sold to the Company’s customers. (3) The amount represents the change in fair value of derivative contracts due to changes in the difference between the spot price and forward price that is excluded from the assessment of hedge effectiveness and, therefore, recognized in earnings.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	3 Months Ended
	Apr. 29, 2017
Equity [Abstract]
ACCUMULATED OTHER COMPREHENSIVE LOSS	ACCUMULATED OTHER COMPREHENSIVE LOSS The activity in accumulated other comprehensive loss for the thirteen weeks ended April 29, 2017 was as follows: Thirteen Weeks Ended April 29, 2017 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at January 28, 2017 $ (126,127 ) $ 4,825 $ (121,302 ) Other comprehensive income (loss) before reclassifications 5,607 (1,373 ) 4,234 Reclassified from accumulated other comprehensive loss (1) — (3,535 ) (3,535 ) Tax effect — 308 308 Other comprehensive income (loss) 5,607 (4,600 ) 1,007 Ending balance at April 29, 2017 $ (120,520 ) $ 225 $ (120,295 ) (1) For the thirteen weeks ended April 29, 2017 , a gain was reclassified from accumulated other comprehensive loss to cost of sales, exclusive of depreciation and amortization on the Condensed Consolidated Statement of Operations and Comprehensive Loss. The activity in accumulated other comprehensive loss for the thirteen weeks ended April 30, 2016 was as follows: Thirteen Weeks Ended April 30, 2016 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at January 30, 2016 $ (119,196 ) $ 4,577 $ (114,619 ) Other comprehensive income (loss) before reclassifications 25,660 (9,382 ) 16,278 Reclassified from accumulated other comprehensive loss (2) — (2,305 ) (2,305 ) Tax effect (5,235 ) 1,732 (3,503 ) Other comprehensive income (loss) 20,425 (9,955 ) 10,470 Ending balance at April 30, 2016 $ (98,771 ) $ (5,378 ) $ (104,149 ) (2) For the thirteen weeks ended April 30, 2016 , a gain was reclassified from accumulated other comprehensive loss to cost of sales, exclusive of depreciation and amortization on the Condensed Consolidated Statement of Operations and Comprehensive Loss.

Segment Reporting

Segment Reporting	3 Months Ended
	Apr. 29, 2017
Segment Reporting [Abstract]
SEGMENT REPORTING	SEGMENT REPORTING The Company has two operating segments: Hollister; and Abercrombie, which includes the Company’s Abercrombie & Fitch and abercrombie kids brands. These operating segments have similar economic characteristics, classes of consumers, products, and production and distribution methods, and have been aggregated into one reportable segment. The following table provides the Company’s net sales by operating segment for the thirteen weeks ended April 29, 2017 and April 30, 2016 . Thirteen Weeks Ended (in thousands) April 29, 2017 April 30, 2016 Hollister $ 374,677 $ 362,147 Abercrombie 286,422 323,336 Total $ 661,099 $ 685,483 The following table provides the Company’s net sales by geographic area for the thirteen weeks ended April 29, 2017 and April 30, 2016 . Thirteen Weeks Ended (in thousands) April 29, 2017 April 30, 2016 United States $ 409,068 $ 425,429 Europe 154,984 161,457 Other 97,047 98,597 Total $ 661,099 $ 685,483

Contingencies

Contingencies	3 Months Ended
	Apr. 29, 2017
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCIES	CONTINGENCIES The Company is a defendant in lawsuits and other adversary proceedings arising in the ordinary course of business. Legal costs incurred in connection with the resolution of claims and lawsuits are generally expensed as incurred, and the Company establishes reserves for the outcome of litigation where losses are deemed probable and reasonably estimable. The Company’s assessment of the current exposure could change in the event of the discovery of additional facts. Actual liabilities may exceed the amounts reserved, and there can be no assurance that final resolution of these matters will not have a material adverse effect on the Company’s financial condition, results of operations or cash flows. There are certain claims and legal proceedings pending against the Company for which accruals have not been established.

Basis of Presentation Nature of

Basis of Presentation Nature of Business (Policies)	3 Months Ended
	Apr. 29, 2017
Basis of Presentation [Abstract]
Nature of Business [Text Block]	Nature of Business Abercrombie & Fitch Co. (“A&F”), through its subsidiaries (collectively, A&F and its subsidiaries are referred to as “Abercrombie & Fitch” or the “Company”), is a specialty retailer of branded apparel and accessories. The Company operates through store and direct-to-consumer operations, as well as through various wholesale, franchise and licensing arrangements. The Company has operations in North America, Europe, Asia and the Middle East.

Basis of Presentation Principle

Basis of Presentation Principles of Consolidation (Policies)	3 Months Ended
	Apr. 29, 2017
Basis of Presentation [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The accompanying Condensed Consolidated Financial Statements include historical financial statements of, and transactions applicable to, the Company and reflect its assets, liabilities, results of operations and cash flows. The Company has interests in a United Arab Emirates business venture and in a Kuwait business venture with Majid al Futtaim Fashion L.L.C. (“MAF”), each of which meets the definition of a variable interest entity (“VIE”). The Company is deemed to be the primary beneficiary of these VIEs; therefore, the Company has consolidated the assets, liabilities, results of operations and cash flows of these VIEs.

Basis of Presentation Fiscal Ye

Basis of Presentation Fiscal Years (Policies)	3 Months Ended
	Apr. 29, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Fiscal Period, Policy [Policy Text Block]	Fiscal Year The Company’s fiscal year ends on the Saturday closest to January 31. All references herein to “Fiscal 2017 ” and “Fiscal 2016 ” represent the fifty-three week fiscal year ending on February 3, 2018 and the fifty-two week fiscal year ended on January 28, 2017 , respectively.

Contingencies (Policies)

Contingencies (Policies)	3 Months Ended
	Apr. 29, 2017
Loss Contingencies [Line Items]
Contingent Liability Reserve Estimate, Policy [Policy Text Block]	The Company is a defendant in lawsuits and other adversary proceedings arising in the ordinary course of business. Legal costs incurred in connection with the resolution of claims and lawsuits are generally expensed as incurred, and the Company establishes reserves for the outcome of litigation where losses are deemed probable and reasonably estimable. The Company’s assessment of the current exposure could change in the event of the discovery of additional facts. Actual liabilities may exceed the amounts reserved, and there can be no assurance that final resolution of these matters will not have a material adverse effect on the Company’s financial condition, results of operations or cash flows. There are certain claims and legal proceedings pending against the Company for which accruals have not been established.

Basis of Presentation Recent Ac

Basis of Presentation Recent Accounting Pronouncements (Tables)	3 Months Ended
	Apr. 29, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]	The following table provides a brief description of recent accounting pronouncements that could affect the Company’s financial statements: Accounting Standards Update (ASU) Description Date of Adoption Effect on the Financial Statements or Other Significant Matters Standards adopted ASU 2015-11, Simplifying the Measurement of Inventory This update amends ASC 330, Inventory . The new guidance applies to inventory measured using first-in, first-out (FIFO) or average cost. Under this amendment, inventory is to be measured at the lower of cost and net realizable value, which is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. January 29, 2017* The adoption of this guidance did not have any impact on the Company's consolidated financial statements. ASU 2016-09, Compensation—Stock Compensation This update amends ASC 718, Compensation . Under the new guidance, tax benefits and certain tax deficiencies arising from the vesting of share-based payments are to be recognized as income tax benefits or expenses in the statement of operations; whereas, under the previous guidance, such benefits and deficiencies were recorded in additional paid-in-capital. The cash flow effects of the tax benefit are to be reported in cash flows from operating activities; whereas, they were previously reported in cash flows from financing activities. This guidance also allows for entities to make a policy election to estimate forfeitures or account for them when they occur. January 29, 2017* As required by the update, all excess tax benefits and tax deficiencies recognized on share-based compensation expense are reflected in the condensed consolidated statements of income as a component of the provision for income taxes on a prospective basis. This update resulted in additional non-cash income tax expense of $9.3 million in the first quarter of Fiscal 2017. In addition, excess tax benefits and tax deficiencies recognized on share-based compensation expense are now classified as an operating activity on the condensed consolidated statements of cash flows. The Company has applied this provision on a retrospective basis. For the first quarter of Fiscal 2016, net cash used by operating activities decreased by $0.6 million with a corresponding offset to net cash used for financing activities. The Company has elected to maintain its practice of estimating forfeitures when recognizing expense for share-based payment awards rather than accounting for forfeitures when they occur. Based on share-based compensation awards currently outstanding at current stock prices, the adoption of this guidance will result in non-cash income tax expense of approximately $11 million for Fiscal 2017 and $20 million for Fiscal 2018. Standards not yet adopted ASU 2014-09, Revenue from Contracts with Customers This update supersedes the revenue recognition requirements in ASC 605, Revenue Recognition . The new guidance requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration which the entity expects to be entitled to in exchange for those goods or services. February 4, 2018 The Company is currently evaluating the impact that this guidance will have on its consolidated financial statements. ASU 2016-02, Leases This update supersedes the leasing requirements in ASC 840, Leases . The new guidance requires an entity to recognize lease assets and lease liabilities on the balance sheet and disclose key leasing information that depicts the lease rights and obligations of an entity. February 3, 2019* The Company expects that this guidance will result in a significant increase in the Company’s long-term assets and long-term liabilities on the Company's consolidated balance sheets, and is currently evaluating additional impacts that it may have on its consolidated financial statements. * Early adoption is permitted.

Net Loss Per Share (Table)

Net Loss Per Share (Table)	3 Months Ended
	Apr. 29, 2017
Earnings Per Share [Abstract]
Schedule of Weighted Average Number of Shares	The following table presents weighted-average shares outstanding and anti-dilutive shares: Thirteen Weeks Ended (in thousands) April 29, 2017 April 30, 2016 Shares of common stock issued 103,300 103,300 Weighted-average treasury shares (35,227 ) (35,675 ) Weighted-average — basic shares 68,073 67,625 Dilutive effect of share-based compensation awards — — Weighted-average — diluted shares 68,073 67,625 Anti-dilutive shares (1) 5,263 7,954 (1) Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net loss per diluted share because the impact would have been anti-dilutive.

Fair Value (Tables)

Fair Value (Tables)	3 Months Ended
	Apr. 29, 2017
Fair Value Disclosures [Abstract]
Company's Assets and Liabilities Measured at Fair Value	The three levels of the hierarchy and the distribution within it of the Company’s assets and liabilities, which are measured at fair value on a recurring basis, were as follows: Assets and Liabilities at Fair Value as of April 29, 2017 (in thousands) Level 1 Level 2 Level 3 Total Assets: Trust-owned life insurance policies (at cash surrender value) $ — $ 100,417 $ — $ 100,417 Money market funds 21 — — 21 Derivative financial instruments — 2,415 — 2,415 Total assets $ 21 $ 102,832 $ — $ 102,853 Liabilities: Derivative financial instruments $ — $ 1,243 $ — $ 1,243 Total liabilities $ — $ 1,243 $ — $ 1,243 Assets at Fair Value as of January 28, 2017 (in thousands) Level 1 Level 2 Level 3 Total Assets: Trust-owned life insurance policies (at cash surrender value) $ — $ 99,654 $ — $ 99,654 Money market funds 94,026 — — 94,026 Derivative financial instruments — 6,042 — 6,042 Total assets $ 94,026 $ 105,696 $ — $ 199,722 Liabilities: Derivative financial instruments $ — $ 492 $ — $ 492 Total liabilities $ — $ 492 $ — $ 492
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]	The carrying amount and fair value of the Company’s term loan facility were as follows: (in thousands) April 29, 2017 January 28, 2017 Gross borrowings outstanding, carrying amount $ 268,250 $ 268,250 Gross borrowings outstanding, fair value $ 258,861 $ 260,551

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	3 Months Ended
	Apr. 29, 2017
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and equipment, net consisted of: (in thousands) April 29, 2017 January 28, 2017 Property and equipment, at cost $ 2,766,557 $ 2,772,139 Less: Accumulated depreciation and amortization (1,960,500 ) (1,947,401 ) Property and equipment, net $ 806,057 $ 824,738

Share-Based Compensation (Table

Share-Based Compensation (Tables)	3 Months Ended
	Apr. 29, 2017
Schedule of Stock Option Activity	The following table summarizes stock option activity for the thirteen weeks ended April 29, 2017 : Number of Underlying Shares Weighted-Average Exercise Price Aggregate Intrinsic Value Weighted-Average Remaining Contractual Life Outstanding at January 28, 2017 189,800 $ 76.62 Granted — — Exercised — — Forfeited or expired (75,000 ) 73.42 Outstanding at April 29, 2017 114,800 $ 78.71 $ — 0.8 Stock options exercisable at April 29, 2017 114,800 $ 78.71 $ — 0.8
Schedule of Stock Appreciation Rights Activity	The following table summarizes stock appreciation rights activity for the thirteen weeks ended April 29, 2017 : Number of Underlying Shares Weighted-Average Exercise Price Aggregate Intrinsic Value Weighted-Average Remaining Contractual Life Outstanding at January 28, 2017 4,079,050 $ 47.49 Granted — — Exercised — — Forfeited or expired (888,197 ) 44.34 Outstanding at April 29, 2017 3,190,853 $ 48.50 $ — 3.0 Stock appreciation rights exercisable at April 29, 2017 2,841,662 $ 51.22 $ — 2.5 Stock appreciation rights expected to become exercisable in the future as of April 29, 2017 267,161 $ 26.63 $ — 7.7
Schedule of Restricted Stock Unit Activity	The following table summarizes activity for restricted stock units for the thirteen weeks ended April 29, 2017 : Service-based Restricted Stock Units Performance-based Restricted Stock Units Market-based Restricted Stock Units Number of Underlying Shares (1) Weighted- Average Grant Date Fair Value Number of Underlying Shares Weighted- Average Grant Date Fair Value Number of Underlying Shares Weighted- Average Grant Date Fair Value Unvested at January 28, 2017 1,915,461 $ 25.47 203,923 $ 22.53 184,892 $ 26.89 Granted 1,408,972 9.61 524,030 9.11 236,872 11.79 Adjustments for performance achievement — — — — — — Vested (466,291 ) 28.86 — — — — Forfeited (122,813 ) 22.37 (5,163 ) 25.15 (5,165 ) 29.55 Unvested at April 29, 2017 2,735,329 $ 16.81 722,790 $ 12.26 416,599 $ 17.25 (1) This includes 786,449 unvested restricted stock units as of April 29, 2017 that are subject to the requirement that the Company must achieve at least $1.00 of GAAP net income attributable to A&F for the fiscal year in order to vest.
Market-based restricted stock units [Member]
Schedule of Weighted-Average Estimated Fair Value and Assumptions of Restricted Stock Units with Market Vesting Conditions	The weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the thirteen weeks ended April 29, 2017 and April 30, 2016 were as follows: April 29, 2017 April 30, 2016 Grant date market price $ 11.43 $ 31.67 Fair value $ 11.79 $ 38.22 Assumptions: Price volatility 47 % 44 % Expected term (years) 2.9 2.8 Risk-free interest rate 1.5 % 1.1 % Dividend yield 7.0 % 2.5 % Average volatility of peer companies 35.2 % 34.4 % Average correlation coefficient of peer companies 0.2664 0.3382

Derivative Instruments (Tables)

Derivative Instruments (Tables)	3 Months Ended
	Apr. 29, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Outstanding Foreign Exchange Forward Contracts	As of April 29, 2017 , the Company had outstanding the following foreign currency exchange forward contracts that were entered into to hedge either a portion, or all, of forecasted foreign-currency-denominated intercompany inventory sales, the resulting settlement of the foreign-currency-denominated intercompany accounts receivable, or both: (in thousands) Notional Amount (1) Euro $ 81,038 British pound $ 30,243 Canadian dollar $ 15,119 Japanese yen $ 7,934 (1) Amounts reported are the U.S. Dollar notional amounts outstanding as of April 29, 2017 . The Company also uses foreign currency exchange forward contracts to hedge certain foreign-currency-denominated net monetary assets/liabilities. Examples of monetary assets/liabilities include cash balances, receivables and payables. Fluctuations in exchange rates result in transaction gains/(losses) being recorded in earnings as U.S. GAAP requires that monetary assets/liabilities be remeasured at the spot exchange rate at quarter-end or upon settlement. The Company has chosen not to apply hedge accounting to these instruments because there are no differences in the timing of gain or loss recognition on the hedging instruments and the hedged items. As of April 29, 2017 , the Company had outstanding the following foreign currency exchange forward contracts that were entered into to hedge foreign-currency-denominated net monetary assets/liabilities: (in thousands) Notional Amount (1) Euro $ 13,895 British pound $ 1,283 (1) Amounts reported are the U.S. Dollar notional amounts outstanding as of April 29, 2017 .
Location and Amounts of Derivative Fair Values on the Condensed Consolidated Balance Sheets	The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets as of April 29, 2017 and January 28, 2017 were as follows: (in thousands) Location April 29, January 28, Location April 29, January 28, Derivatives designated as hedging instruments: Foreign currency exchange forward contracts Other current assets $ 2,415 $ 5,920 Accrued expenses $ 1,226 $ 486 Derivatives not designated as hedging instruments: Foreign currency exchange forward contracts Other current assets $ — $ 122 Accrued expenses $ 17 $ 6 Total Other current assets $ 2,415 $ 6,042 Accrued expenses $ 1,243 $ 492
Location and Amounts of Derivative Gains and Losses on the Condensed Consolidated Statements of Operations and Comprehensive Loss	The location and amounts of derivative gains and losses for the thirteen weeks ended April 29, 2017 and April 30, 2016 on the Condensed Consolidated Statements of Operations and Comprehensive Loss were as follows: Thirteen Weeks Ended April 29, 2017 April 30, 2016 (in thousands) Location Gain/(Loss) Gain/(Loss) Derivatives not designated as hedging instruments: Foreign currency exchange forward contracts Other operating income, net $ 28 $ (1,777 ) Effective Portion Ineffective Portion and Amount Excluded from Effectiveness Testing Amount of Loss Recognized in OCI on Derivative Contracts (1) Location of Gain Reclassified from AOCL into Earnings Amount of Gain Reclassified from AOCL into Earnings (2) Location of Gain Recognized in Earnings on Derivative Contracts Amount of Gain Recognized in Earnings on Derivative Contracts (3) Thirteen Weeks Ended (in thousands) April 29, April 30, April 29, April 30, April 29, April 30, Derivatives in cash flow hedging relationships: Foreign currency exchange forward contracts $ (1,373 ) $ (9,382 ) Cost of sales, exclusive of depreciation and amortization $ 3,535 $ 2,305 Other operating income, net $ 528 $ 355 (1) The amount represents the change in fair value of derivative contracts due to changes in spot rates. (2) The amount represents the reclassification from AOCL into earnings when the hedged item affects earnings, which is when merchandise is sold to the Company’s customers. (3) The amount represents the change in fair value of derivative contracts due to changes in the difference between the spot price and forward price that is excluded from the assessment of hedge effectiveness and, therefore, recognized in earnings.

Accumulated Other Comprehensi26

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Apr. 29, 2017
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Loss	The activity in accumulated other comprehensive loss for the thirteen weeks ended April 29, 2017 was as follows: Thirteen Weeks Ended April 29, 2017 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at January 28, 2017 $ (126,127 ) $ 4,825 $ (121,302 ) Other comprehensive income (loss) before reclassifications 5,607 (1,373 ) 4,234 Reclassified from accumulated other comprehensive loss (1) — (3,535 ) (3,535 ) Tax effect — 308 308 Other comprehensive income (loss) 5,607 (4,600 ) 1,007 Ending balance at April 29, 2017 $ (120,520 ) $ 225 $ (120,295 ) (1) For the thirteen weeks ended April 29, 2017 , a gain was reclassified from accumulated other comprehensive loss to cost of sales, exclusive of depreciation and amortization on the Condensed Consolidated Statement of Operations and Comprehensive Loss. The activity in accumulated other comprehensive loss for the thirteen weeks ended April 30, 2016 was as follows: Thirteen Weeks Ended April 30, 2016 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at January 30, 2016 $ (119,196 ) $ 4,577 $ (114,619 ) Other comprehensive income (loss) before reclassifications 25,660 (9,382 ) 16,278 Reclassified from accumulated other comprehensive loss (2) — (2,305 ) (2,305 ) Tax effect (5,235 ) 1,732 (3,503 ) Other comprehensive income (loss) 20,425 (9,955 ) 10,470 Ending balance at April 30, 2016 $ (98,771 ) $ (5,378 ) $ (104,149 ) (2) For the thirteen weeks ended April 30, 2016 , a gain was reclassified from accumulated other comprehensive loss to cost of sales, exclusive of depreciation and amortization on the Condensed Consolidated Statement of Operations and Comprehensive Loss.

Segment Reporting (Tables)

Segment Reporting (Tables)	3 Months Ended
	Apr. 29, 2017
Segment Reporting [Abstract]
Revenue from External Customers by Operating Segment [Table Text Block]	The following table provides the Company’s net sales by operating segment for the thirteen weeks ended April 29, 2017 and April 30, 2016 . Thirteen Weeks Ended (in thousands) April 29, 2017 April 30, 2016 Hollister $ 374,677 $ 362,147 Abercrombie 286,422 323,336 Total $ 661,099 $ 685,483
Revenue from External Customers by Geographic Areas [Table Text Block]	The following table provides the Company’s net sales by geographic area for the thirteen weeks ended April 29, 2017 and April 30, 2016 . Thirteen Weeks Ended (in thousands) April 29, 2017 April 30, 2016 United States $ 409,068 $ 425,429 Europe 154,984 161,457 Other 97,047 98,597 Total $ 661,099 $ 685,483

Net Loss Per Share (Details)

Net Loss Per Share (Details) - shares shares in Thousands		3 Months Ended
		Apr. 29, 2017	Apr. 30, 2016
Weighted Average Shares Outstanding And Anti Dilutive Shares [Abstract]
Shares of common stock issued		103,300	103,300
Weighted-average treasury shares		(35,227)	(35,675)
Weighted-average — basic shares		68,073	67,625
Dilutive effect of share-based compensation awards		0	0
Weighted-average — diluted shares		68,073	67,625
Anti-dilutive shares (1)	[1]	5,263	7,954
[1]	Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net loss per diluted share because the impact would have been anti-dilutive.

Fair Value (Assets and Liabilit

Fair Value (Assets and Liabilities at Fair Value) (Details) - USD ($)	Apr. 29, 2017	Jan. 28, 2017
Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restricted Investments, Noncurrent	$ 100,417,000	$ 99,654,000
Assets, Fair Value Disclosure [Abstract]
Money market funds	21,000	94,026,000
Derivative financial instruments	2,415,000	6,042,000
Total assets	102,853,000	199,722,000
Liabilities, Fair Value Disclosure [Abstract]
Derivative financial instruments	1,243,000	492,000
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]
Liabilities, Fair Value Disclosure, Recurring	1,243,000	492,000
Level 1 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restricted Investments, Noncurrent	0	0
Assets, Fair Value Disclosure [Abstract]
Money market funds	21,000	94,026,000
Derivative financial instruments	0	0
Total assets	21,000	94,026,000
Liabilities, Fair Value Disclosure [Abstract]
Derivative financial instruments	0	0
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]
Liabilities, Fair Value Disclosure, Recurring	0	0
Level 2 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restricted Investments, Noncurrent	100,417,000	99,654,000
Assets, Fair Value Disclosure [Abstract]
Money market funds	0	0
Derivative financial instruments	2,415,000	6,042,000
Total assets	102,832,000	105,696,000
Liabilities, Fair Value Disclosure [Abstract]
Derivative financial instruments	1,243,000	492,000
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]
Liabilities, Fair Value Disclosure, Recurring	1,243,000	492,000
Level 3 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restricted Investments, Noncurrent	0	0
Assets, Fair Value Disclosure [Abstract]
Money market funds	0	0
Derivative financial instruments	0	0
Total assets	0	0
Liabilities, Fair Value Disclosure [Abstract]
Derivative financial instruments	0	0
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]
Liabilities, Fair Value Disclosure, Recurring	0	0
Term Loan Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gross borrowings outstanding, carrying amount	268,250,000	268,250,000
Gross borrowings outstanding, fair value	258,861,000	260,551,000
ABL Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Credit facility, amount outstanding	$ 0	$ 0

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016	Jan. 28, 2017
Property, Plant and Equipment [Line Items]
Property and equipment, at cost	$ 2,766,557		$ 2,772,139
Less: Accumulated depreciation and amortization	(1,960,500)		(1,947,401)
Property and equipment, net	806,057		824,738
Asset Impairment Charges	730	$ 0
Construction Project Assets [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, net	$ 35,900		$ 35,600

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Income Tax Disclosure [Abstract]
Net tax deficit on share-based compensation	$ 9,264	$ 951

Share-Based Compensation (Detai

Share-Based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 4,880	$ 6,599
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	1,900	2,500
Tax benefit recognized related to share-based compensation expense	$ 2,100	4,900
Target percentage of equity awards earned	100.00%
Stock Appreciation Rights
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	$ 2,100
Unrecognized compensation cost, weighted-average period of recognition	11 months
Total grant date fair value of awards vested	$ 1,900	3,700
Service-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	$ 30,100
Unrecognized compensation cost, weighted-average period of recognition	17 months
Total grant date fair value of awards granted	$ 13,540	21,445
Total grant date fair value of awards vested	13,457	12,892
Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	$ 4,900
Unrecognized compensation cost, weighted-average period of recognition	18 months
Total grant date fair value of awards granted	$ 4,774	2,762
Total grant date fair value of awards vested	0	1,151
Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	$ 4,800
Unrecognized compensation cost, weighted-average period of recognition	16 months
Total grant date fair value of awards granted	$ 2,793	3,601
Total grant date fair value of awards vested	$ 0	$ 0
Minimum | Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned	0.00%
Minimum | Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned	0.00%
Maximum | Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned	200.00%
Maximum | Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned	200.00%

Share-Based Compensation (Stock

Share-Based Compensation (Stock Option Activity) (Details)	3 Months Ended
	Apr. 29, 2017USD ($)$ / sharesshares
Stock Option Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 28, 2017 | shares	189,800
Number of Underlying Shares, Granted | shares	0
Number of Underlying Shares, Exercised | shares	0
Number of Underlying Shares, Forfeited or expired | shares	(75,000)
Number of Underlying Shares, Ending Balance at April 29, 2017 | shares	114,800
Number of Underlying Shares, Stock options exercisable at April 29, 2017 | shares	114,800
Stock Option Activity, Weighted Average Exercise Price
Weighted-Average Exercise Price, Beginning Balance at January 30, 2016 | $ / shares	$ 76.62
Weighted-Average Exercise Price, Granted | $ / shares	0
Weighted-Average Exercise Price, Exercised | $ / shares	0
Weighted-Average Exercise Price, Forfeited or expired | $ / shares	73.42
Weighted-Average Exercise Price, Ending Balance at October 29, 2016 | $ / shares	78.71
Weighted-Average Exercise Price, Stock options exercisable | $ / shares	$ 78.71
Aggregate Intrinsic Value, Outstanding | $	$ 0
Aggregate Intrinsic Value, Stock options exercisable | $	$ 0
Weighted-Average Remaining Contractual Life (in years), Outstanding	9 months 18 days
Weighted-Average Remaining Contractual Life (in years), Stock options exercisable	9 months 18 days

Share-Based Compensation (Sto34

Share-Based Compensation (Stock Appreciation Rights Activity) (Details) - Stock Appreciation Rights - USD ($)	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	$ 1,900,000	$ 3,700,000
Stock Appreciation Rights Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 28, 2017	4,079,050
Number of Underlying Shares, Granted	0
Number of Underlying Shares, Exercised	0
Number of Underlying Shares, Forfeited	(888,197)
Number of Underlying Shares, Ending Balance at April 29, 2017	3,190,853
Number of Underlying shares, Stock appreciation rights exercisable	2,841,662
Number of Underlying Shares, Stock appreciation rights expected to become exercisable	267,161
Stock Appreciation Rights, Weighted-Average Exercise Price
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2016	$ 47.49
Weighted-Average Exercise Price, Granted	0
Weighted-Average Exercise Price, Exercised	0
Weighted-Average Exercise Price, Forfeited or expired	44.34
Weighted-Average Grant Date Fair Value, Ending Balance at October 29, 2016	48.50
Weighted-Average Exercise Price, Stock appreciation rights exercisable	51.22
Weighted-Average Exercise Price, Stock appreciation rights expected to become exercisable	$ 26.63
Aggregate Intrinsic Value, Outstanding	$ 0
Aggregate Intrinsic Value, Stock appreciation rights exercisable	0
Aggregate Intrinsic Value, Stock appreciation rights expected to become exercisable	$ 0
Weighted-Average Remaining Contractual Life, Outstanding	3 years
Weighted-Average Remaining Contractual Life, Stock appreciation rights exercisable	2 years 6 months
Weighted Average Remaining Contractual Life, Stock appreciation rights expected to become exercisable	7 years 8 months 12 days

Share-Based Compensation (Restr

Share-Based Compensation (Restricted Stock Units Activity) (Details) - $ / shares		3 Months Ended
		Apr. 29, 2017	Apr. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned		100.00%
Service-based restricted stock units with $1.00 net income requirement [Member]
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Ending Balance at April 29, 2017		786,449
Service-based restricted stock units
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 28, 2017		1,915,461
Number of Underlying Shares, Granted		1,408,972
Number of Underlying Shares, Adjustments for performance achievement		0
Number of Underlying Shares, Vested		(466,291)
Number of Underlying Shares, Forfeited		(122,813)
Number of Underlying Shares, Ending Balance at April 29, 2017	[1]	2,735,329
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2016		$ 25.47
Weighted-Average Grant Date Fair Value, Granted		9.61
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement		0
Weighted-Average Grant Date Fair Value, Vested		28.86
Weighted-Average Grant Date Fair Value, Forfeited		22.37
Weighted-Average Grant Date Fair Value, Ending Balance at October 29, 2016		$ 16.81
Performance-based restricted stock units [Member]
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 28, 2017		203,923
Number of Underlying Shares, Granted		524,030
Number of Underlying Shares, Adjustments for performance achievement		0
Number of Underlying Shares, Vested		0
Number of Underlying Shares, Forfeited		(5,163)
Number of Underlying Shares, Ending Balance at April 29, 2017		722,790
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2016		$ 22.53
Weighted-Average Grant Date Fair Value, Granted		9.11
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement		0
Weighted-Average Grant Date Fair Value, Vested		0
Weighted-Average Grant Date Fair Value, Forfeited		25.15
Weighted-Average Grant Date Fair Value, Ending Balance at October 29, 2016		$ 12.26
Market-based restricted stock units [Member]
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 28, 2017		184,892
Number of Underlying Shares, Granted		236,872
Number of Underlying Shares, Adjustments for performance achievement		0
Number of Underlying Shares, Vested		0
Number of Underlying Shares, Forfeited		(5,165)
Number of Underlying Shares, Ending Balance at April 29, 2017		416,599
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2016		$ 26.89
Weighted-Average Grant Date Fair Value, Granted		11.79	$ 38.22
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement		0
Weighted-Average Grant Date Fair Value, Vested		0
Weighted-Average Grant Date Fair Value, Forfeited		29.55
Weighted-Average Grant Date Fair Value, Ending Balance at October 29, 2016		$ 17.25
Minimum | Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned		0.00%
Minimum | Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned		0.00%
Maximum | Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned		200.00%
Maximum | Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned		200.00%
[1]	(1) This includes 786,449 unvested restricted stock units as of April 29, 2017 that are subject to the requirement that the Company must achieve at least $1.00 of GAAP net income attributable to A&F for the fiscal year in order to vest.

Share-Based Compensation (Res36

Share-Based Compensation (Restricted Stock Units Assumptions) (Details) - Market-based restricted stock units [Member]	3 Months Ended
	Apr. 29, 2017$ / shares	Apr. 30, 2016$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant date market price (in dollars per share)	$ 11.43	$ 31.67
Fair value (in dollars per share)	$ 11.79	$ 38.22
Price volatility	47.00%	44.00%
Expected term (years)	2 years 10 months 24 days	2 years 9 months 18 days
Risk-free interest rate	1.50%	1.10%
Dividend yield	7.00%	2.50%
Average volatility of peer companies	35.20%	34.40%
Average correlation coefficient of peer companies	0.2664	0.3382

Derivative Instruments (Outstan

Derivative Instruments (Outstanding Foreign Exchange Forward Contracts) (Details) - Cash Flow Hedging - Forward Contracts $ in Thousands	Apr. 29, 2017USD ($)	[1]
Inter-company Inventory and Accounts Receivables [Member] | Euro Member Countries, Euro
Derivative [Line Items]
Notional Amount	$ 81,038
Inter-company Inventory and Accounts Receivables [Member] | United Kingdom, Pounds
Derivative [Line Items]
Notional Amount	30,243
Inter-company Inventory and Accounts Receivables [Member] | Canada, Dollars
Derivative [Line Items]
Notional Amount	15,119
Inter-company Inventory and Accounts Receivables [Member] | Japan, Yen
Derivative [Line Items]
Notional Amount	7,934
Assets and Liabilities | Euro Member Countries, Euro
Derivative [Line Items]
Notional Amount	13,895
Assets and Liabilities | United Kingdom, Pounds
Derivative [Line Items]
Notional Amount	$ 1,283
[1]	Amounts reported are the U.S. Dollar notional amounts outstanding as of April 29, 2017.

Derivative Instruments (Derivat

Derivative Instruments (Derivative Fair Values on the Condensed Consolidated Balance Sheets) (Details) - USD ($) $ in Thousands	Apr. 29, 2017	Jan. 28, 2017
Foreign currency exchange forward contracts | Other current assets | Designated As Hedging Instrument
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Other current assets	$ 2,415	$ 5,920
Foreign currency exchange forward contracts | Other current assets | Not Designated as Hedging Instruments
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Other current assets	0	122
Foreign currency exchange forward contracts | Accrued expenses | Designated As Hedging Instrument
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Accrued expenses	1,226	486
Foreign currency exchange forward contracts | Accrued expenses | Not Designated as Hedging Instruments
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Accrued expenses	17	6
Fair Value, Measurements, Recurring
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Other current assets	2,415	6,042
Accrued expenses	1,243	492
Level 2 | Fair Value, Measurements, Recurring
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Other current assets	2,415	6,042
Accrued expenses	$ 1,243	$ 492

Derivative Instruments (Deriv39

Derivative Instruments (Derivative Gains (Losses) on the Condensed Consolidated Statement of Operations) (Details) - Foreign currency exchange forward contracts - USD ($) $ in Thousands		3 Months Ended
		Apr. 29, 2017	Apr. 30, 2016
Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in OCI on Derivative Contracts (Effective Portion)	[1]	$ (1,373)	$ (9,382)
Other operating income, net
Derivative Instruments, Gain (Loss) [Line Items]
Gain/(Loss)		28	(1,777)
Other operating income, net | Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain Recognized in Earnings on Derivative Contracts (Ineffective Portion and Amount Excluded from Effectiveness Testing)	[2]	528	355
Cost of sales, exclusive of depreciation and amortization | Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Reclassified from AOCL into Earnings (Effective Portion)	[3]	$ 3,535	$ 2,305
[1]	The amount represents the change in fair value of derivative contracts due to changes in spot rates.
[2]	The amount represents the change in fair value of derivative contracts due to changes in the difference between the spot price and forward price that is excluded from the assessment of hedge effectiveness and, therefore, recognized in earnings.
[3]	The amount represents the reclassification from AOCL into earnings when the hedged item affects earnings, which is when merchandise is sold to the Company’s customers.

Derivative Instruments (Details

Derivative Instruments (Details) - USD ($) $ in Thousands		3 Months Ended
		Apr. 29, 2017	Apr. 30, 2016	Jan. 28, 2017
Derivative Instruments, Gain (Loss) [Line Items]
Length of time inventory sales hedged (in months)		12 months
Period in which remaining unrealized gains or losses on intercompany inventory sales are recognized		12 months
Foreign currency exchange forward contracts | Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Recognized in OCI, Effective Portion, Net	[1]	$ (1,373)	$ (9,382)
Foreign currency exchange forward contracts | Cost of sales, exclusive of depreciation and amortization | Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	[2]	3,535	2,305
Foreign currency exchange forward contracts | Other operating income, net | Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain Recognized in Earnings, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net	[3]	528	$ 355
Fair Value, Measurements, Recurring
Derivative Instruments, Gain (Loss) [Line Items]
Other current assets		2,415		$ 6,042
Accrued expenses		1,243		492
Level 2 | Fair Value, Measurements, Recurring
Derivative Instruments, Gain (Loss) [Line Items]
Other current assets		2,415		6,042
Accrued expenses		$ 1,243		$ 492
[1]	The amount represents the change in fair value of derivative contracts due to changes in spot rates.
[2]	The amount represents the reclassification from AOCL into earnings when the hedged item affects earnings, which is when merchandise is sold to the Company’s customers.
[3]	The amount represents the change in fair value of derivative contracts due to changes in the difference between the spot price and forward price that is excluded from the assessment of hedge effectiveness and, therefore, recognized in earnings.

Accumulated Other Comprehensi41

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017		Apr. 30, 2016
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance at January 28, 2017	$ (121,302)		$ (114,619)
Other comprehensive income (loss) before reclassifications	4,234		16,278
Reclassified from accumulated other comprehensive loss (1)	(3,535)	[1]	(2,305)	[2]
Tax effect	308		(3,503)
Other comprehensive income	1,007		10,470
Ending balance at April 29, 2017	(120,295)		(104,149)
Foreign Currency Translation Adjustment
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance at January 28, 2017	(126,127)		(119,196)
Other comprehensive income (loss) before reclassifications	5,607		25,660
Reclassified from accumulated other comprehensive loss (1)	0		0
Tax effect	0		(5,235)
Other comprehensive income	5,607		20,425
Ending balance at April 29, 2017	(120,520)		(98,771)
Unrealized Gain (Loss) on Derivative Financial Instruments
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance at January 28, 2017	4,825		4,577
Other comprehensive income (loss) before reclassifications	(1,373)		(9,382)
Reclassified from accumulated other comprehensive loss (1)	(3,535)		(2,305)
Tax effect	308		1,732
Other comprehensive income	(4,600)		(9,955)
Ending balance at April 29, 2017	$ 225		$ (5,378)
[1]	For the thirteen weeks ended April 29, 2017, a gain was reclassified from accumulated other comprehensive loss to cost of sales, exclusive of depreciation and amortization on the Condensed Consolidated Statement of Operations and Comprehensive Loss.
[2]	For the thirteen weeks ended April 30, 2016, a gain was reclassified from accumulated other comprehensive loss to cost of sales, exclusive of depreciation and amortization on the Condensed Consolidated Statement of Operations and Comprehensive Loss.

Segment Reporting (Segment Repo

Segment Reporting (Segment Reporting Information, by Segment) (Details) $ in Thousands	3 Months Ended
	Apr. 29, 2017USD ($)	Apr. 30, 2016USD ($)
Segment Reporting Information [Line Items]
Number of Operating Segments	2
Number of reportable segments	1
Net Sales	$ 661,099	$ 685,483

Segment Reporting (Net Sales by

Segment Reporting (Net Sales by Brand) (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Schedule of Revenue by Brand [Line Items]
Net Sales	$ 661,099	$ 685,483
Hollister
Schedule of Revenue by Brand [Line Items]
Net Sales	374,677	362,147
Abercrombie
Schedule of Revenue by Brand [Line Items]
Net Sales	$ 286,422	$ 323,336

Segment Reporting (Sales by Geo

Segment Reporting (Sales by Geographic Area) (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 29, 2017	Apr. 30, 2016
Net Sales	$ 661,099	$ 685,483
United States
Net Sales	409,068	425,429
Europe
Net Sales	154,984	161,457
Other
Net Sales	$ 97,047	$ 98,597